Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2028?

Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2028? It is currently trading at a 31% probability on Kalshi. Scheduled resolution: January 1, 2032.

Last updated October 16, 2026 at 11:17 PM ET

Current Market Probability

Probability Price Platform Status Resolution date Chart
31% 0.31 Kalshi Open January 01, 2032 View chart

Market Information

Historical Market Probability

7 days ago 30 days ago Current
31% 41% 31%

Related Prediction Markets

Popular Prediction Markets